【2h】

Structural basis for NKG2A/CD94 recognition of HLA-E

机译:NKG2A / CD94识别HLA-E的结构基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The NKG2x/CD94 (x = A, C, E) natural killer-cell receptors perform an important role in immunosurveillance by binding to HLA-E complexes that exclusively present peptides derived from MHC class I leader sequences, thereby monitoring MHC class I expression. We have determined the crystal structure of the NKG2A/CD94/HLA-E complex at 4.4-Å resolution, revealing two critical aspects of this interaction. First, the C-terminal region of the peptide, which displays the most variability among class I leader sequences, interacts entirely with CD94, the invariant component of these receptors. Second, residues 167–170 of NKG2A/C account for the ≈6-fold-higher affinity of the inhibitory NKG2A/CD94 receptor compared to its activating NKG2C/CD94 counterpart. These residues do not contact HLA-E or peptide directly but instead form part of the heterodimer interface with CD94. An evolutionary analysis across primates reveals that whereas CD94 is evolving under purifying selection, both NKG2A and NKG2C are evolving under positive selection. Specifically, residues at the CD94 interface have evolved under positive selection, suggesting that the evolution of these genes is driven by an interaction with pathogen-derived ligands. Consistent with this possibility, we show that NKG2C/CD94, but not NKG2A/CD94, weakly but specifically binds to the CMV MHC-homologue UL18. Thus, the evolution of the NKG2x/CD94 family of receptors has likely been shaped both by the need to bind the invariant HLA-E ligand and the need to avoid subversion by pathogen-derived decoys.
机译:NKG2x / CD94(x = A,C,E)自然杀伤细胞受体通过与HLA-E复合物结合而在免疫监视中发挥重要作用,该复合物专门呈现源自MHC I类前导序列的肽,从而监控MHC I类表达。我们已经确定了NKG2A / CD94 / HLA-E复合物的晶体结构,分辨率为4.4Å,揭示了这种相互作用的两个关键方面。首先,在I类前导序列中表现出最大变异性的肽的C末端区域与这些受体的不变成分CD94完全相互作用。其次,与激活的NKG2C / CD94对应物相比,NKG2A / C的残基167-170导致抑制性NKG2A / CD94受体的亲和力高约6倍。这些残基不直接接触HLA-E或肽,而是与CD94形成异二聚体界面的一部分。跨灵长类动物的进化分析显示,尽管CD94在纯化选择下进化,但NKG2A和NKG2C在阳性选择下都进化。具体而言,CD94界面处的残基在正选择下已进化,表明这些基因的进化受与病原体衍生的配体相互作用的驱动。与此可能性相符,我们显示NKG2C / CD94而非NKG2A / CD94弱但特异性结合CMV MHC同源物UL18。因此,NKG2x / CD94受体家族的进化可能是由于需要结合不变的HLA-E配体,而且需要避免被病原体衍生的诱饵破坏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号